BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11566607)

  • 1. Receptor tyrosine kinase signalling as a target for cancer intervention strategies.
    Zwick E; Bange J; Ullrich A
    Endocr Relat Cancer; 2001 Sep; 8(3):161-73. PubMed ID: 11566607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor tyrosine kinases as target for anti-cancer therapy.
    Brunelleschi S; Penengo L; Santoro MM; Gaudino G
    Curr Pharm Des; 2002; 8(22):1959-72. PubMed ID: 12171522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of receptor tyrosine kinases by viral-encoded growth factors.
    Lateef Z; Wise LM
    Growth Factors; 2018 Aug; 36(3-4):118-140. PubMed ID: 31084274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
    Andrechek ER; Muller WJ
    Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive responses to antibody based therapy.
    Rodems TS; Iida M; Brand TM; Pearson HE; Orbuch RA; Flanigan BG; Wheeler DL
    Semin Cell Dev Biol; 2016 Feb; 50():153-63. PubMed ID: 26808665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase receptors as attractive targets of cancer therapy.
    Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic Cleavage of Receptor Tyrosine Kinases.
    Huang H
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell signaling by receptor tyrosine kinases.
    Lemmon MA; Schlessinger J
    Cell; 2010 Jun; 141(7):1117-34. PubMed ID: 20602996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion.
    Nakada M; Kita D; Teng L; Pyko IV; Watanabe T; Hayashi Y; Hamada JI
    Adv Exp Med Biol; 2020; 1202():151-178. PubMed ID: 32034713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling.
    Liebmann C; Böhmer FD
    Curr Med Chem; 2000 Sep; 7(9):911-43. PubMed ID: 10911023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective downregulation of receptor tyrosine kinases in cancer.
    Bache KG; Slagsvold T; Stenmark H
    EMBO J; 2004 Jul; 23(14):2707-12. PubMed ID: 15229652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor tyrosine kinases: legacy of the first two decades.
    Schlessinger J
    Cold Spring Harb Perspect Biol; 2014 Mar; 6(3):. PubMed ID: 24591517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of receptor tyrosine kinase signals.
    Fiorini M; Alimandi M; Fiorentino L; Sala G; Segatto O
    FEBS Lett; 2001 Feb; 490(3):132-41. PubMed ID: 11223028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor Tyrosine Kinases in Development: Insights from
    Mele S; Johnson TK
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
    Vanderlaag K; Wang W; Fayadat-Dilman L; Wagner J; Bald L; Grein J; Janatpour MJ
    Int J Cancer; 2012 Mar; 130(6):1251-63. PubMed ID: 21445968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
    Prenzel N; Fischer OM; Streit S; Hart S; Ullrich A
    Endocr Relat Cancer; 2001 Mar; 8(1):11-31. PubMed ID: 11350724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors.
    Choura M; Rebaï A
    Biol Direct; 2010 Oct; 5():58. PubMed ID: 20937105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of receptor tyrosine kinase activation in cancer.
    Du Z; Lovly CM
    Mol Cancer; 2018 Feb; 17(1):58. PubMed ID: 29455648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.